Revised Procedure for Reporting Blood Bank Activity
Beginning June 1, 2014, all licensed blood banks and transfusion services in Massachusetts will be required to report transfusion related adverse events using the Centers for Disease Control and Prevention (CDC) National Healthcare Safety Network (NHSN) Hemovigilance Module.
Reporting transfusion related adverse events to NHSN DOES NOT replace reporting patient death or serious injury associated with unsafe administration of blood products as a Serious Reportable Event, 105 CMR 130.332(A) . Unsafe administration includes, but is not limited to, hemolytic reactions and administering: a) blood or blood products to the wrong patient; b) the wrong type; c) blood or blood products that have been improperly stored or handled. All such events should be reported to the Clinical Laboratory Program within one business day at (617)753-8439 or 753-7307.